Pfizer secret government contracts8/9/2023 In recent months, Pfizer has begun to ramp up vaccine deliveries quickly outside the richest nations. It hasn’t spelled out how it will price or distribute the pill, but since production is limited in the near term, vaccines remain the central weapon against the pandemic. Pfizer further cemented its front-runner status in the pandemic when it announced in early November that it had developed a Covid pill that cut hospitalizations and deaths by 89%. 1 Covid vaccine source for the wealthiest countries. The distribution data show Pfizer is the No. With its German partner BioNTech, the New York-based company produces and distributes the biggest supply of one of the most effective vaccines, which is expected to generate $36 billion in revenue this year. AstraZeneca, which initially pledged to sell its vaccine at cost during the pandemic, quickly ramped up its supply to poorer countries, largely by licensing its formula to a producer in India. The single-dose Johnson & Johnson vaccine, which arrived months after the three others, turned out to be a relatively small player. and Europe, Chief Executive Officer Stephane Bancel told Bloomberg on Nov. Moderna, which had never produced a licensed drug product before Covid, barely expanded from supplying wealthier nations until recently, mostly because of export restrictions and early supply commitments to the U.S. But then they took different paths, data compiled by London-based Airfinity shows. Pfizer, Moderna, AstraZeneca and Johnson & Johnson began a year ago on similar footing-sending most of their doses to wealthy countries rather than poor ones. Yet the demands, debates and decisions that brought vaccine producers to this point are only now coming into focus. Americans and Europeans flush with vaccines are beginning to put the pandemic in the past, while the coronavirus still rolls across much of the world. The broad implications of today’s lopsided global supply are clear. A sticking point in that effort is who gets to control secret vaccine formulas worth billions of dollars. Nearly a year after the first shots went into arms, Western vaccine producers and public health officials are still struggling to find common ground to close a yawning gap between some nations only 6% of people in Africa were fully inoculated as of early November. It was the result of decisions by corporate executives and government officials. Their previously unreported exchange laid bare an uncomfortable truth: Vaccine inequality didn’t happen by itself. “Actually, I’m not being emotional,” Tedros said, stressing that there was an urgent need to get more vaccines into arms. Photographer: Christopher Goodney/Bloomberg CEO, speaks with Bloomberg reporters in New York on Nov.
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |